The TGF-β family, in particular TGF-β1, is the most promising potential biomarker for mixed IPMN, as it was detected in three of the five mixed IPMN samples and none of the BD-IPMN samples. Here, TGFB1 is linked to pancreatic intraductal papillary-mucinous neoplasm.